Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 273 clinical trials
Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers

This is a Phase 1, single-dose, open-label, randomized, three-period, three-way crossover study in which healthy adult participants will receive three separate single-dose administrations of ASTX660 capsules under three different conditions.

systolic blood pressure
body mass index
oophorectomy
tubal ligation
hysterectomy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients

Participants will be devided into intervention group and placebo group in an 1:1 ratio.They will:In the treatment period for 12 weeks, intervention group receives postbiotics product while the other group receives placebo.In the subsequent 12 weeks, intervention group ends the trial and placebo group enters into remedial treatment period.

  • 0 views
  • 16 May, 2025
Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

A Randomized, 4-Period, Crossover Study to characterize the effects of tolperisone 200 mg and 400 mg (supratherapeutic dose) three times a day (TID) over 3 days of dosing on measures of simulated driving performance, cognitive function and drowsiness and compared to placebo and cyclobenzaprine (single-day, residual effect, multiple-day).

  • 0 views
  • 19 Feb, 2024
  • 2 locations
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

This study is a one-arm, open, phase II clinical study, and the study subjects are locally advanced and inflammatoryPatients with sexual or early HER2-positive breast cancer entered the trial period after signing informed consentTo evaluate trastuzumab combined with pyrrolitinib and chemotherapy regimen (TCbH+Py) for HER2 positive breastPathologic complete response rate …

primary lesion
bisphosphonate therapy
ejection fraction
invasive breast cancer
her2+ breast cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

Half of the patients will receive tocotrienol and the other half placebo. Treatment is planned for a period of maximum six months and will be discontinued earlier in case of progression or unacceptable toxicity.

serum bilirubin
capecitabine
investigational treatment
metastatic colorectal cancer
colorectal cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Ultra - Brief Crisis IPT-A Based Intervention for Suicidal Children and Adolescents (IPT-A-SCI)

The current adaptation of IPT-A is comprised of five weekly sessions, followed by monthly follow-up caring email contacts to the patients and their parents, over a period of three months.

suicide
depressive symptoms
psychotherapy
depression
suicidal
  • 0 views
  • 19 Feb, 2024
  • 1 location
Benefits of Exercise in Alzheimer's Disease

This study will involve 30 randomized patients to take part in the out-patient exercise program and 30 patients to continue with their regular activities over a 6-month period. Once that period is over, half of the 30 patients who participated in the outpatient exercise program will continue in the program …

aerobic exercise
behavioral symptoms
neuropsychological test
alzheimer's disease
dementia
  • 4 views
  • 19 Feb, 2024
  • 1 location
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

The study consists of a 6 month randomized, double blind, placebo-controlled period, followed by 1 year of treatment with crinecerfont. Duration of participation is approximately 20 months.

congenital adrenal hypoplasia
adrenaline
deficiency
  • 0 views
  • 19 Feb, 2024
  • 1 location
Evaluation of a New Supporting Ostomy Product

It is the expectation that median wear time is slightly reduced in the period when subjects are using the supporting product with their ostomy appliance. Long-term benefits of the test product may be less skin redness, less worry of leakage and/or improvement in quality of life and social activities.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer

Tolerance of the endocrine therapy will be assessed by patient reported outcome (PRO) measures during neoadjuvant and adjuvant endocrine therapy treatment periods. Breast cancer participants and their surgical oncologists will be asked their preference regarding radiation therapy before starting endocrine therapy and again post-operatively.

anastrozole
tamoxifen
invasive breast cancer
estrogen receptor positive breast cancer
HER2
  • 0 views
  • 19 Feb, 2024
  • 1 location